Retraction
Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K/AKT/mTOR signaling pathway to improve diabetic erectile dysfunction
Paper Information
Record ID:
59280
Author(s):
Publication Date:
September 03, 2024
Retraction Date:
December 02, 2024
(<1 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0314890Citations (4)
4
Total Citations2
Post-Retraction(50.0%)
0
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
211
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
IGF1R as a Protective Target in Antidiabetic Drug-mediated Prevention of Erectile Dysfunction: Insights from Genetics
Yuqi Li, Juan Wang, Tao Zhou et al. (6 authors)
Reproductive Toxicology
Published: Jul 2025
211 days after retraction
NFKB1-targeted metabolites as novel therapeutic approaches for erectile dysfunction: evidence from gut microbiota network pharmacology and machine learning
Boyu Xiang, Jinshun An, Dongjie Li
Sexual Medicine
Open Access
Published: May 2025
180 days after retraction
Retraction: Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K/AKT/mTOR signaling pathway to improve diabetic erectile dysfunction
Unknown Authors
PLoS ONE
Open Access
Published: Dec 2024
Same day as retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 24, 2025